Search BTSG
BrightSpring Health Services, Inc.
Nasdaq, Nasdaq · CIK 1865782
Last close60.25
Daily change+2.99 (5.22%)
10 Years gain+447.73%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
BTSG · STANDARD
SIC 8082 · Services-Home Health Care Services · Fiscal year end 1231
Fundamental
52.8Momentum
58.8Acceleration
65.9Confidence
73.0Annual Revenue4
Quarterly Revenue12
Annual CFO4
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth18.4 / 25
Quality17.2 / 25
Capital Efficiency5.7 / 20
Balance Sheet6.5 / 15
Shareholder Economics0.0 / 10
Forward Indicators5.0 / 5
Signals
Gross margin expansionGross margin improved by 0.0606 percentage points.
Operating leverageOperating margin improved by 1.7684 percentage points.
ROIC expansionROIC improved by 5.2766 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.
Warnings
Low interest coverage · HIGHInterest coverage is 2.5457x.
Key Metrics
Revenue Growth TTM36.9%OK
Revenue CAGR 3Y18.69%OK
Gross Margin12.47%OK
Operating Margin2.78%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC8.67%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y2.49%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $12.91B | $1.52B | $295.25M | $490.17M | $394.69M | 11.76% | 2.29% | 3.06% | 5.28% | 219.77M |
| 2025 FY Dec 31, 2024 | $10.07B | $1.27B | $107.95M | $23.77M | -$57.14M | 12.57% | 1.07% | -0.57% | 2.1% | 193M |
| 2025 FY Dec 31, 2023 | $7.69B | $1.14B | $58.13M | $210.78M | $137.26M | 14.81% | 0.76% | 1.78% | n/a | 117.87M |
| 2024 FY Dec 31, 2022 | $7.72B | $1.35B | $187.83M | -$4.65M | -$74.77M | 17.54% | 2.43% | -0.97% | n/a | 117.84M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $13.97B | sum latest 4 fiscal quarters Revenue | OK | 0001193125-26-327014, 0001193125-25-253631 |
| Revenue Growth TTM | 36.9% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001193125-26-327014, 0001193125-25-253631 |
| Revenue CAGR 3Y | 18.69% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001193125-26-079454 |
| Revenue CAGR 5Y | n/a | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | INSUFFICIENT_HISTORY | 0001193125-26-079454 |
| Gross Profit CAGR 3Y | 3.87% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001193125-26-079454 |
| Operating Income Growth | 276.37% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001193125-26-327014, 0001193125-25-253631 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 12.47% | Gross Profit / Revenue | OK | 0001193125-26-327014, 0001193125-25-253631 |
| Operating Margin | 2.78% | Operating Income / Revenue | OK | 0001193125-26-327014, 0001193125-25-253631 |
| ROIC | 8.67% | NOPAT / Average Invested Capital | OK | 0001193125-26-327014, 0001193125-25-253631 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001193125-26-327014 |
| Interest Coverage | 2.55x | Operating Income / abs(Interest Expense) | OK | derived |
| Current Ratio | 1.59x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.25x | (Cash + Short-term Investments) / Total Debt | OK | 0001193125-26-327014 |